Blog - Page 3 of 99 - VisionGate

January 28, 2021

VisionGate Presents at the World Conference on Lung Cancer for 2020: LuCED® Sputum Test for Assessment of Lung Cancer Risk in COPD Patients: Sensitivity and Specimen Satisfactory Rate
More Information
Research
January 12, 2021

#10,890,595:
METHOD AND APPARATUS FOR PRE-POSITIONING A RADIALLY SYMMETRIC, COAXIAL SAMPLE WITHIN A SHEATH FLUID TO PROVIDE UNIFORM SAMPLE DELIVERY RATE DURING FLOW
More Information
Patents
November 12, 2020

Patients FAQ’s
More Information
News
August 25, 2020

#10,753,857:
APPARATUS AND METHOD FOR MEASURING MICROSCOPIC OBJECT VELOCITIES IN FLOW
More Information
Patents
September 28, 2018

VisionGate Presents at the 2018 conference of the American Thoracic Society: Positive Rate Of The Lung Cell Evaluation (LuCED) Test For Patients With Chronic Obstructive Pulmonary Disease (COPD)
More Information
Research
September 28, 2018

VisionGate Presents at the World Conference on Lung Cancer for 2018 in Toronto: Malignancy Associated Change and The LuCED® Test for Detection of Early Stage Lung Cancer
More Information
Research
April 5, 2018

VisionGate is Leveraging the Cell-CT™ Platform to Expand Cancer Diagnostics Services
More Information
News
October 16, 2017

VisionGate Presents at the World Conference on Lung Cancer for 2017 in Tokyo: Effect of Tumor Size on the Sensitivity of the Non-Invasive LuCED® Test for Lung Cancer
More Information
Research
October 16, 2017

VisionGate Presents at the World Conference on Lung Cancer for 2017 in Tokyo: Morphometric Genotyping Identifies Lung Cancer Cells Harboring Target Mutations; Cell-CT® Platform Detects Gene Abnormalities
More Information
Research
October 16, 2017

VisionGate Presents at the World Conference on Lung Cancer for 2017 in Tokyo: Cell-CT® Differential Detection of Dysplastic Bronchial Epithelial Cells from Patient Explants
More Information
Research

Previous 234 Next